# Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell Transplantation

> **NCT00889278** · — · COMPLETED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 30 (actual)

## Conditions studied

- Lymphoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00889278
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2012-03-01
- **Final completion:** 2016-01-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00889278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00889278, "Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell Transplantation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00889278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*